Ticker

Profitability This table compares Vaxxinity and Evotec's net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Vaxxinity N/A N/A N/A Evotec 20.85% 16.02% 7.81% Risk and Volatility Vaxxinity has a beta of 1.12, suggesting that its share price is 12% more volatile than the S&P 500. Comparatively,

Vaxxinity (NASDAQ: VAXX - Get Free Report) and iBio (NYSE: IBIO - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, earnings, profitability, valuation, risk, institutional ownership and dividends. Analyst Ratings This is a summary of current ratings